Therapeutic Potential of Natural Compounds that Regulate the Activity of Protein Kinase C
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2883-2902
Author(s):
Charleata A. Carter and Cynthia J. M. Kane
Alphaviruses and their Derived Vectors as Anti-Tumor Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
597-607
Author(s):
Gregory J. Atkins, James W. P. Smyth, Marina N. Fleeton, Sareen E. Galbraith and Brian J. Sheahan
Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3239-3262
Author(s):
Clifton E. Barry, Helena I.M. Boshoff and Cynthia S. Dowd
Neoplastic Conditions in the Context of HIV-1 Infection
Journal:
Current HIV Research
Volume:
2
Page:
343-349
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
Radionuclide Imaging in Drug Development
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2907-2921
Author(s):
Alan C. Perkins and Malcolm Frier
Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
Oncogene Suppression by Small Interfering RNAs
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
349-354
Author(s):
Olaf Heidenreich
Silencing of Disease-related Genes by Small Interfering RNAs
Journal:
Current Molecular Medicine
Volume:
4
Page:
507-517
Author(s):
U. Fuchs, C. Damm-Welk and A. Borkhardt
Small Molecule Toxins Targeting Tumor Receptors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2311-2334
Author(s):
Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan